Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 411 results for "adap"

Adaptimmune Puts Fludarabine Back On The Agenda

If Adaptimmune's (NASDAQ: ADAP ) only problem was the lack of responses in the first six patients enrolled into its ovarian cancer study of NY-ESO Spear then its 8% slide yesterday could easily be called an overreaction. However, the initial data ... Seeking Alpha, 1 week ago

36 images for adap

WKRB News, 1 week ago
International Development Research Centre, 1 week ago, 1 week ago
American Banking News, 1 week ago
SleekMoney, 1 week ago
Octafinance, 3 weeks ago
Daily Nation, 3 weeks ago
Daily Nation, 3 weeks ago
SleekMoney, 3 weeks ago
RFPConnect, 2 months ago

Healthcare - Top 5 Gainers / Losers as of 11:00

Gainers: HTGM +69%. NSPR +31%. TRXC +8%. IPCI +6%. IDRA +6%. Losers: BSPM -17%. RXII -11%. ADAP -11%. TBPH -9%. XXII -7%. Now read: Biotech Forum Daily Digest: Better Times Ahead For Mylan? Revisiting The Investment Case On Aratana Therapeutics ...
 Seeking Alpha1 week ago
American Banking News

Adaptimmune Therapeutics PLC (ADAP) Receives Consensus Rating of Buy from Brokerages

Shares of Adaptimmune Therapeutics PLC (NASDAQ:ADAP) have received a consensus recommendation of Buy from the six research firms that are covering the firm. One research analyst has rated the stock with a hold recommendation and five have given a ...
 American Banking News4 days ago ADAPTIMMUNE THERAPEUTICS PLC (NASDAQ : ADAP) Files An 8-K  4 Traders4 days ago Adaptimmune Announces Initiation of Triple Tumor Study to Evaluate its SPEARĀ® T-Cell Therapy Targeting MAGE-A10  International Business Times5 days ago Adaptimmune Provides Update on Study of NY-ESO SPEARĀ® T-cell Therapy in Synovial Sarcoma at the European Society for Medical Oncology (ESMO) 2016 Congress  4 Traders2 weeks ago

Adaptimmune Is The Current Leader In T-Cell Receptor Immunotherapy In Cancers

Adaptimmune (NASDAQ: ADAP ) was established by licensing the T-cell receptor technology licensed from the Oxford University and in collaboration with University of Pennsylvania. The company is developing its TCR therapy for treatment of various ...
 Seeking Alpha3 weeks ago

Here's What We Want To See From Adaptimmune Therapeutics PLC ADR (NASDAQ:ADAP)

Earlier in August, we highlighted Adaptimmune Therapeutics PLC ADR (NASDAQ:ADAP) as being a company to watch going forward, with a specific focus on the company's pipeline. We noted that, while the company looked interesting, there were some ...
 4 Traders1 week ago ADAPTIMMUNE THERAPEUTICS PLC ADR (NASDAQ : ADAP) Files An 8-K  4 Traders1 week ago

Sarawak jemah ila bepanggai ba pemansang adap ke utara menua

SAMALAJU: Palan Industri Samalaju enggau industri kuasa intensif beguna amat nyadi chunto ba pengawa nempa Sarawak nyadi nengeri industri jemah ila, pia ku Tuai Megai Menua (TYT) Tun Pehin Sri Abdul Taib Mahmud. Jemah ila Sarawak deka bepanggai ba ...
 MySarawak4 days ago

HIV Care Grant Program - Part BStates/Territories Formula and AIDS Drug Assistance Program Formula and ADAP Supplemental Awards

Funding Opportunity ID: 289068 Opportunity Number: HRSA-17-036 Opportunity Title: Opportunity Category: Discretionary Opportunity Category Explanation: Funding Instrument Type: Grant Category of Funding Activity: Health Category Explanation: ...
 Grants.gov1 month ago AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)  Grants.gov1 month ago Ryan White HIV/AIDS Program Part B AIDS Drug Assistance Program Training and Technical Assistance  Grants.gov6 days ago

Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women's Interagency HIV Study, 20062009

Background: Implementation of the Affordable Care Act motivates assessment of health insurance and supplementary programs, such as the AIDS Drug Assistance Program (ADAP) on health outcomes of HIV-infected people in the United States. We assessed ...
 JAIDS1 week ago

US Federal Business Opportunity: Department of the Navy: ADAP Lab Fiber Switches

Tags: News: Hardware Tenders:USA This was published: 13 Oct 2016 - 02:48 pm Tweet Agency: Department of the Navy Office: Naval Air Systems Command Location: NAVAIR HQ Date you need to respond by: 24-October-2016 Classification Code: 70 -- ...
 ITbriefing1 week ago

Adaptimmune stock slides after poor efficacy forces it to add fludarabine to regimen

Adaptimmune ($ADAP) has responded to the failure of its T-cell therapy to induce objective clinical responses in ovarian cancer patients by adding fludarabine to the preconditioning regimen. Investors reacted to the lack of efficacy and addition of ...
 FierceBiotech1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less